Exact sequential test for clinical trials and post-market drug and vaccine safety surveillance with Poisson and binary data
From MaRDI portal
Publication:6627990
DOI10.1002/SIM.9094zbMATH Open1546.62694MaRDI QIDQ6627990
Ivair Silva, M. Kulldorff, Judith C. Maro
Publication date: 29 October 2024
Published in: Statistics in Medicine (Search for Journal in Brave)
Cites Work
- Title not available (Why is that?)
- Title not available (Why is that?)
- Title not available (Why is that?)
- A Maximized Sequential Probability Ratio Test for Drug and Vaccine Safety Surveillance
- Statistical approaches to interim monitoring of medical trials: A review and commentary
- Type I error probability spending for post-market drug and vaccine safety surveillance with Poisson data
- Continuous versus group sequential analysis for post-market drug and vaccine safety surveillance
- Discrete Sequential Boundaries for Clinical Trials
- Approximately Optimal One-Parameter Boundaries for Group Sequential Trials
- Design and analysis of group sequential tests based on the type I error spending rate function
- Efficient Score Statistic in Drug and Vaccine Safety Surveillance
- Exact group sequential designs for two-arm experiments with Poisson distributed outcome variables
- Optimal Alpha Spending for Sequential Analysis with Binomial Data
- Exact conditional maximized sequential probability ratio test adjusted for covariates
- Sequential Tests of Statistical Hypotheses
- Alpha spending for historical versus surveillance Poisson data with CMaxSPRT
- Exact sequential analysis for multiple weighted binomial end points
Related Items (2)
A seasonality-adjusted sequential test for vaccine safety surveillance ⋮ The person-time ratio distribution for the exact monitoring of adverse events: historical vs surveillance Poisson data
This page was built for publication: Exact sequential test for clinical trials and post-market drug and vaccine safety surveillance with Poisson and binary data
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6627990)